Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1997
08/21/1997WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
08/21/1997WO1997030149A1 Novel era
08/21/1997WO1997030088A2 Methods of treating vascular disease with tnf antagonists
08/21/1997WO1997030085A1 Troponin subunits and fragments useful as angiogenesis inhibitors
08/21/1997WO1997030082A2 Antifungic and antibacterial peptide
08/21/1997WO1997030078A1 DERIVATIVES OF ANTIBIOTIC GE2270 FACTORS C2a, D2 AND E
08/21/1997WO1997030073A1 Serine protease inhibitors
08/21/1997WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii
08/21/1997WO1997030070A1 Novel compounds
08/21/1997WO1997030069A1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase
08/21/1997WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/21/1997WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents
08/21/1997WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents
08/21/1997WO1997030053A1 Farnesyl transferase inhibitors
08/21/1997WO1997030048A1 1,4-dihydropyridine compounds as bradykinin antagonists
08/21/1997WO1997030046A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/21/1997WO1997030045A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
08/21/1997WO1997030044A1 Quinazoline compounds
08/21/1997WO1997030042A1 Polyester cyclic compounds, their complexes and bonded bodies
08/21/1997WO1997030041A1 Non-steroidal polycyclic ring sulphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors
08/21/1997WO1997030031A1 Esters of 3-hydroxy-piperidinemethanol derivatives
08/21/1997WO1997030030A1 Indole derivatives
08/21/1997WO1997030029A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
08/21/1997WO1997030027A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
08/21/1997WO1997030019A1 Aniline derivatives having antihyperglycemic activity
08/21/1997WO1997029842A1 Solid and semi-solid hydrocarbon gels and uses thereof
08/21/1997WO1997029780A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
08/21/1997WO1997029778A2 Bioresponsive pharmacologically-active polymers and articles made therefrom
08/21/1997WO1997029775A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
08/21/1997WO1997029774A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
08/21/1997WO1997029772A1 Recombinant canine herpesviruses
08/21/1997WO1997029769A1 Vaccine for b-cell malignancies
08/21/1997WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997WO1997029760A1 Multifunctional fat absorption and blood cholesterol reducing formulation containing chitosan and nicotinic acid
08/21/1997WO1997029759A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin
08/21/1997WO1997029758A2 Use of azithromycin and tinidazole for the eradication of helicobacter pylori
08/21/1997WO1997029757A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
08/21/1997WO1997029756A1 Method of treating otitis media with uridine triphosphates and related compounds
08/21/1997WO1997029755A1 Aqueous laxative syrup comprising lactulose and lactitol and/or maltitol
08/21/1997WO1997029753A1 New associations of active principles containing clopidogrel and an antithrombotic agent
08/21/1997WO1997029752A1 Storage-stable prostaglandin compositions
08/21/1997WO1997029751A1 Use of leukotriene b4 or its analogues as antiviral and antineoplastic agents
08/21/1997WO1997029750A1 Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders
08/21/1997WO1997029749A1 Therapeutic agent for kidney diseases
08/21/1997WO1997029748A1 Substituted biphenyl isoxazole sulfonamides
08/21/1997WO1997029747A1 Methods for the preparation of biphenyl isoxazole sulfonamides
08/21/1997WO1997029746A1 Inhibition of protein glycation and prevention of vasculopathy
08/21/1997WO1997029745A1 Zwitterionic compositions and methods as biological response modifiers
08/21/1997WO1997029744A1 Neovascularization inhibitor
08/21/1997WO1997029743A1 Il-8 receptor antagonists
08/21/1997WO1997029742A1 Lubricating and/or germicidal composition
08/21/1997WO1997029741A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
08/21/1997WO1997029740A1 Multiple sclerosis treatment
08/21/1997WO1997029739A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
08/21/1997WO1997029735A1 Dermal penetration enhancers and drug delivery systems involving same
08/21/1997WO1997029635A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor
08/21/1997WO1997029630A1 A method of preventing animals from diseases and improving immune function of animals
08/21/1997WO1997023613A3 Cell activation process and reagents therefor
08/21/1997WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
08/21/1997WO1997014806A3 Delivery of biologically active polypeptides
08/21/1997WO1997007136A3 Pharmaceutical composition containing inhibitors of interferon-gamma
08/21/1997DE19612504A1 Muscarine agonist and peripherally active anti-muscarine composition
08/21/1997DE19606926A1 Verwendung von Azithromycin und Tinidazol zur Eradikation von Helicobacter pylori Use of azithromycin and tinidazole for eradication of Helicobacter pylori
08/21/1997DE19606151A1 Ibuprofen-Brausezubereitung sowie Verfahren zur Herstellung derselben Effervescent ibuprofen preparation as well as methods for making same
08/21/1997DE19605659A1 Compositions containing beta-carotene and vitamin=E
08/21/1997CA2749312A1 Sugar-modified gapped oligonucleotides
08/21/1997CA2634973A1 Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
08/21/1997CA2432662A1 Il-8 receptor antagonists
08/21/1997CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/21/1997CA2246712A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation
08/21/1997CA2246581A1 Method of treating otitis media with uridine triphosphates and related compounds
08/21/1997CA2246578A1 Novel human myeloid terminal differentiation response gene
08/21/1997CA2246503A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections
08/21/1997CA2246418A1 Neovascularization inhibitor
08/21/1997CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein
08/21/1997CA2246356A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
08/21/1997CA2246336A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
08/21/1997CA2246256A1 Serine protease inhibitors
08/21/1997CA2246230A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
08/21/1997CA2245927A1 Il-8 receptor antagonists
08/21/1997CA2245863A1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin
08/21/1997CA2245830A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
08/21/1997CA2245727A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
08/21/1997CA2245684A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
08/21/1997CA2245579A1 Spiro-ketal derivatives and their use as therapeutic agents
08/21/1997CA2245578A1 Spiro-ketal derivatives and their use as therapeutic agents
08/21/1997CA2245518A1 Antifungic and antibacterial peptide
08/21/1997CA2244823A1 17-beta-cyclopropyl(amino/oxy) 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and c17-20-lyase
08/21/1997CA2244144A1 Aqueous laxative syrup comprising lactulose and lactitol and/or maltitol
08/21/1997CA2243662A1 Recombinant canine herpesviruses
08/21/1997CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997CA2242136A1 Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobials
08/21/1997CA2242067A1 Derivatives of antibiotic ge2270 factors c2a, d2 and e
08/21/1997CA2241891A1 Quinolones and their therapeutic use
08/21/1997CA2240043A1 Substituted biphenyl isoxazole sulfonamides
08/21/1997CA2230639A1 Zwitterionic compositions and methods as biological response modifiers
08/21/1997CA2216465A1 Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
08/20/1997EP0790254A1 Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them
08/20/1997EP0790250A2 Inhibitors of biogenic amine transporters
08/20/1997EP0790248A1 3-Aza-piperidone- (tetrahydropyrimidin-2-one) and 3-oxa-piperidone (1,3 oxazin-2-one) derivatives, their preparation and their use as tachykinin/neurokinin antagonists
1 ... 6759 6760 6761 6762 6763 6764 6765 6766 6767 6768 6769 6770 6771 6772 6773 6774 6775 6776 6777 6778 6779 ... 7860